Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients
Lercanidipine demonstrated comparable effectiveness to amlodipine in preventing MACE among hypertensive patients. Given its comparable antihypertensive efficacy and potential for fewer side effects based on prior studies, lercanidipine may be considered a preferable option for hypertension management.
Authors
- Jinsung Jeon (ORCID: https://orcid.org/0009-0001-9465-3656)
- Eung Ju Kim (ORCID: https://orcid.org/0000-0003-2322-6267)
- Cheol Woong Yu (ORCID: https://orcid.org/0000-0002-5871-4562)
- Seung Mok Ryoo (ORCID: https://orcid.org/0000-0002-2436-3311)
- Hyung Joon Joo (ORCID: https://orcid.org/0000-0003-1846-8464)
- Soon Jun Hong (ORCID: https://orcid.org/0000-0003-4832-6678)
- Yong Hyun Kim (ORCID: https://orcid.org/0000-0002-5015-7685)
- Seungmi Oh
Institutions
- Korea University (KR)
- Korea University Medical Center (KR)
- Ansan University (KR)
- Korea University (JP)
Publication Details
- Journal
- American Journal of Hypertension
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1093/ajh/hpae147
- Citations
- 3
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.21